In February last year we announced a partnership with Intellectual Ventures’ Global Good fund, to develop a test to support cervical cancer screening in low- and middle-income countries (LMICs). We are jointly developing
QuantuMDx is dedicated to making transformative, quality diagnostic technologies accessible to everyone, so that diseases can be detected and treated earlier, and transmission eradicated.
